Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

Nature Medicine

Volumn 7, Issue 12, 2001, Pages 1320-1326

  Belyakov, Igor M ^a   Hel, Zdenek ^a   Kelsall, Brian ^b   Kuznetsov, Vladimir A ^c   Ahlers, Jeffrey D ^a   Nacsa, Janos ^a   Watkins, David I ^d   Allen, Todd M ^d   Sette, Alessandro ^e   Altman, John ^f   Woodward, Ruth ^g   Markham, Phillip D ^g   Clements, John D ^h   Franchini, Genoveffa ^a   Strober, Warren ^b   Berzofsky, Jay A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

^e Epimmune   (United States)

^f EMORY UNIVERSITY   (United States)

^g ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^h TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, RECTAL; AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTESTINAL MUCOSA; MACACA MULATTA; MOLECULAR SEQUENCE DATA; RECTUM; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION; VACCINES, SYNTHETIC; VIRAL LOAD;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; PRIMATES; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035661880     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1201-1320     Document Type: Article

References (44)

1. + T cell depletion and viral replication in SIV infection
2. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
3. Approaches to improve engineered vaccines for human immunodeficiency virus (HIV) and other viruses that cause chronic infections
4. A rational basis for mucosal vaccination against HIV infection
5. Mucosal immunity and tolerance: Relavance to vaccine development
6. + cytotoxic T lymphocytes for resistance to mucosal-viral transmission in mice and enhancement of resistance by local administration of IL-12
7. Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific cytotoxic T lymphocytes
8. Selective induction of protective MHC class I restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa
9. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi
10. Construction of peptides encompassing multideterminant clusters of HIV envelope to induce in vitro T-cell responses in mice and humans of multiple MHC types
11. An immunodominant epitope of the HIV gp 160 envelope glycoprotein recognized by class I MHC molecule-restricted murine cytotoxic T lymphocytes
12. Construction of an HIV- 1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations
13. Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization
14. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes
15. + cytotoxic T cells in vivo by carrier-free HIV synthetic peptides
16. + cytotoxic T lymphocytes in Rhesus monkeys
17. − memory T cells to clear rotavirus infection
18. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys
19. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex
20. + lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: Implications for vaccine design and testing
21. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity
22. Effectiveness of intranasal immunization with HIV-gp160 Env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)
23. − T cells and AIDS in pig-tailed macaques
24. + T cell loss and AIDS in rhesus macaques
25. + cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys
26. Ranks-score tests in factorial designs with repeated measures
27. Nonparametric methods in factorial designs
28. HIV-specific cytotoxic T lymphocytes in seropositive individuals
29. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
30. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus
31. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
32. Induction of mucosal CTL response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing HIV 89.6 envelope protein
33. + T cell responses associated with control of viremia
34. + CTL in vivo with peptide vaccine constructs
35. Enhanced immunogenicity of HIV- 1 vaccine construct by modification of the native peptide sequence
36. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
37. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor B1 and B2 chain expression
38. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
39. A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing
40. Isolation and functional characterization of human intestinal mucosal lymphoid cells
41. Priming with helper T-cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV 1 in primates
42. Phenotypic analysis of antigen-specific T lymphocytes
43. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys
44. Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology